Assignee
MERUS NV
NL·43 granted patents·54 pending applications·170 citations·filing 2013–2025
Top patents by PatentIndex Score
97 records- 0197US11926859B2Methods and means for the production of Ig-like moleculesMERUS NV·Filed 2023·Granted Mar 12, 2024·2 cites·7 claims
- 0297US9758805B2Methods and means for the production of Ig-like moleculesMERUS NV·Filed 2015·Granted Sep 12, 2017·23 cites·43 claims
- 0396US12139548B2Antibody that binds ErbB-2 and ErbB-3MERUS NV·Filed 2022·Granted Nov 12, 2024·4 cites·20 claims
- 0495US12247078B2ERBB-2 and ERBB-3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion geneMERUS NV·Filed 2024·Granted Mar 11, 2025·3 cites·20 claims
- 0595US10605808B2Antibody producing non-human animalsMERUS NV·Filed 2016·Granted Mar 31, 2020·19 cites·9 claims
- 0694US11237165B2Antibody producing non-human animalsMERUS NV·Filed 2017·Granted Feb 1, 2022·5 cites·14 claims
- 0794US10752929B2Methods and means for the production of ig-like moleculesMERUS NV·Filed 2019·Granted Aug 25, 2020·5 cites·15 claims
- 0894US10670599B2Method for selecting a single cell expressing a heterogeneous combination of antibodiesMERUS NV·Filed 2017·Granted Jun 2, 2020·6 cites·13 claims
- 0993US10934571B2Recombinant production of mixtures of antibodiesMERUS NV·Filed 2016·Granted Mar 2, 2021·4 cites·20 claims
- 1093US9951124B2Antibody producing non-human mammalsMERUS NV·Filed 2013·Granted Apr 24, 2018·10 cites·4 claims
- 1192US10844127B2Antibodies that bind EGFR and ErbB3MERUS NV·Filed 2015·Granted Nov 24, 2020·8 cites·18 claims
- 1292US10647781B2Generation of binding moleculesMERUS NV·Filed 2017·Granted May 12, 2020·6 cites·7 claims
- 1392US9914777B2Human CD3 binding antibodyMERUS NV·Filed 2016·Granted Mar 13, 2018·11 cites·18 claims
- 1491US11820825B2Methods of treating a subject having an EGFR-positive and/or ErbB-3-positive tumorMERUS NV·Filed 2020·Granted Nov 21, 2023·2 cites·12 claims
- 1591US11408095B2Generation of binding moleculesMERUS NV·Filed 2020·Granted Aug 9, 2022·2 cites·7 claims
- 1690US11279770B2Antibody that binds ErbB-2 and ErbB-3MERUS NV·Filed 2015·Granted Mar 22, 2022·7 cites·17 claims
- 1790US2024344102A1Methods and means for the production of ig-like moleculesMERUS NV·Filed 2024·Application pending·0 cites
- 1889US11559049B2Antibody producing non-human animalsMERUS NV·Filed 2018·Granted Jan 24, 2023·2 cites·7 claims
- 1989US10358492B2Bispecific IgG antibodies as T cell engagersMERUS NV·Filed 2013·Granted Jul 23, 2019·11 cites·30 claims
- 2088US12123043B2Methods and means for the production of Ig-like moleculesMERUS NV·Filed 2020·Granted Oct 22, 2024·1 cites·26 claims
- 2188US10329596B2Methods and means for the production of Ig-like moleculesMERUS NV·Filed 2016·Granted Jun 25, 2019·4 cites·34 claims
- 2288US10266593B2Human CD3 binding antibodyMERUS NV·Filed 2018·Granted Apr 23, 2019·6 cites·19 claims
- 2387US11993654B2PD-1 binding domainsMERUS NV·Filed 2022·Granted May 28, 2024·1 cites·20 claims
- 2487US11732043B2Antibodies that modulate a biological activity expressed by a cellMERUS NV·Filed 2018·Granted Aug 22, 2023·3 cites·22 claims
- 2587US10337045B2Methods and means for the production of Ig-like moleculesMERUS NV·Filed 2017·Granted Jul 2, 2019·3 cites·56 claims
- 2687US2024023527A1Antibody producing non-human animalsMERUS NV·Filed 2023·Application pending·0 cites
- 2787US2024156072A1Antibody producing non-human animalsMERUS NV·Filed 2023·Application pending·0 cites
- 2886US11780925B2ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion geneMERUS NV·Filed 2018·Granted Oct 10, 2023·5 cites·15 claims
- 2985US12195551B2Combination of an ErbB-2/ErbB-3 bispecific antibody with endocrine therapy for breast cancerMERUS NV·Filed 2018·Granted Jan 14, 2025·3 cites·9 claims
- 3085US11667714B2Binding molecules that modulate a biological activity expressed by a cellMERUS NV·Filed 2018·Granted Jun 6, 2023·3 cites·48 claims
- 3183US2024158532A1Antibody that binds erbb-2 and erbb-3MERUS NV·Filed 2024·Application pending·0 cites
- 3282US11753470B2Bispecific anti PD1-anti TIM3 antibodiesMERUS NV·Filed 2018·Granted Sep 12, 2023·2 cites·14 claims
- 3381US12291798B2Generation of binding moleculesMERUS NV·Filed 2022·Granted May 6, 2025·0 cites·12 claims
- 3481US11952424B2Multivalent antibodyMERUS NV·Filed 2019·Granted Apr 9, 2024·1 cites·47 claims
- 3581US2024158531A1Antibody that binds erbb-2 and erbb-3MERUS NV·Filed 2024·Application pending·0 cites
- 3681US2024109966A1Human cd3 binding antibodyMERUS NV·Filed 2023·Application pending·0 cites
- 3781US2025026823A1Bispecific igg antibodies as t cell engagersMERUS NV·Filed 2024·Application pending·0 cites
- 3881US2025230579A1Generation of binding moleculesMERUS NV·Filed 2025·Application pending·0 cites
- 3980US11939394B2Binding molecules that inhibit cancer growthMERUS NV·Filed 2016·Granted Mar 26, 2024·4 cites·30 claims
- 4080US2024352127A1Multivalent antibodyMERUS NV·Filed 2024·Application pending·0 cites
- 4180US2024360217A1Multivalent antibodyMERUS NV·Filed 2024·Application pending·0 cites
- 4278US11873338B2CLEC12AxCD3 bispecific antibodies and methods for the treatment of diseaseMERUS NV·Filed 2019·Granted Jan 16, 2024·2 cites·13 claims
- 4378US2022348683A1Antibody that binds erbb-2 and erbb-3MERUS NV·Filed 2022·Application pending·0 cites
- 4478US2024052043A1Antibodies that bind egfr and erbb3MERUS NV·Filed 2023·Application pending·0 cites
- 4578US2024199747A1Erbb-2 and erbb3 binding bispecific antibodies for use in the treatment of cells that have an nrg1 fusion geneMERUS NV·Filed 2023·Application pending·0 cites
- 4676US11685786B2Binding molecules that bind CD137 and PD-L1MERUS NV·Filed 2017·Granted Jun 27, 2023·1 cites·10 claims
- 4776US2024425594A1Novel pd-1 binding domainsMERUS NV·Filed 2024·Application pending·0 cites
- 4876US2024425595A1Novel pd-1 binding domainsMERUS NV·Filed 2024·Application pending·0 cites
- 4973US12577306B2Bispecific anti PD1-anti TIM3 antibodiesMERUS NV·Filed 2023·Granted Mar 17, 2026·0 cites·28 claims
- 5073USRE47770ERecombinant production of mixtures of antibodiesMERUS NV·Filed 2016·Granted Dec 17, 2019·1 cites·26 claims
Showing the top 50 of 97 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when MERUS NV files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →